Literature DB >> 25841474

Dopamine receptor antagonists.

Howard S Smith1, Lorrain R Cox2, Benjamin R Smith3.   

Abstract

Intractable nausea and/or vomiting is a serious and significant clinical dilemma that may greatly detract from quality of life. One of the first classes of antiemetic agents used as well as one of the commonest classes of antiemetic agents used is that of the dopamine receptor antagonists. Dopamine receptor antagonists are useful antiemetic agents, however, unfortunately, clinicians have on occasion resorted to switching from one dopamine receptor antagonist to another dopamine receptor antagonist when the initial dopamine receptor antagonist was ineffective rather than adding on a second antiemetic agent from a totally different class (e.g., 5-HT3 receptor antagonists, NK-1 receptor antagonists).

Entities:  

Keywords:  Nausea; butyrophenones; dopamine receptor antagonists; metoclopramide; phenothiazines; vomiting

Year:  2012        PMID: 25841474     DOI: 10.3978/j.issn.2224-5820.2012.07.09

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  8 in total

1.  Pharmacological therapies for autism spectrum disorder: a review.

Authors:  Sheena LeClerc; Deidra Easley
Journal:  P T       Date:  2015-06

Review 2.  Antiemetic drugs: what to prescribe and when.

Authors:  Akshay Athavale; Tegan Athavale; Darren M Roberts
Journal:  Aust Prescr       Date:  2020-04-01

3.  Gastrointestinal symptoms in postural tachycardia syndrome: a systematic review.

Authors:  Shahram E Mehr; Adrian Barbul; Cyndya A Shibao
Journal:  Clin Auton Res       Date:  2018-03-16       Impact factor: 4.435

4.  SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).

Authors:  R de Las Peñas; A Blasco; J De Castro; Y Escobar; R García-Campelo; A Gúrpide; R Lopez-Lopez; M Majem; C A Rodríguez; J A Virizuela
Journal:  Clin Transl Oncol       Date:  2016-11-28       Impact factor: 3.405

5.  Systematic Morphometry of Catecholamine Nuclei in the Brainstem.

Authors:  Domenico Bucci; Carla L Busceti; Maria T Calierno; Paola Di Pietro; Michele Madonna; Francesca Biagioni; Larisa Ryskalin; Fiona Limanaqi; Ferdinando Nicoletti; Francesco Fornai
Journal:  Front Neuroanat       Date:  2017-11-02       Impact factor: 3.856

6.  Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers.

Authors:  Gabriel M Fox; Ad F Roffel; Jan Hartstra; Linda A Bussian; Sjoerd P van Marle
Journal:  Clin Pharmacol       Date:  2019-12-02

7.  Metabolomic Profiles of the Creeping Wood Sorrel Oxalis corniculata in Radioactively Contaminated Fields in Fukushima: Dose-Dependent Changes in Key Metabolites.

Authors:  Ko Sakauchi; Wataru Taira; Joji M Otaki
Journal:  Life (Basel)       Date:  2022-01-13

8.  Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK-906), a Novel Selective D2 /D3 Receptor Antagonist: A Phase 1 Randomized, Placebo-Controlled Single- and Multiple-Dose Escalation Study in Healthy Participants.

Authors:  Roger L Whiting; Borje Darpo; Chunlin Chen; Margaret Fletcher; Dan Combs; Hongqi Xue; Randall R Stoltz
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.